PROFOUND MEDICAL CORP. Operating Cash Flow
PROFOUND MEDICAL CORP. (PROF) reported Operating Cash Flow of -$19.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$11.34M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.58M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.57M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$9.61M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for fiscal 2025 was -$38.21M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for fiscal 2024 was -$23.45M.
- PROFOUND MEDICAL CORP. net cash provided by (used in) operating activities for fiscal 2023 was -$22.61M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$19.92M 10-Q · filed 2026-08-06 | -$26.49M derived: sum of 3 quarters · filed 2026-08-06 | -$36.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.58M 10-Q · filed 2026-05-07 | -$15.15M derived: sum of 2 quarters · filed 2026-05-07 | -$24.76M derived: sum of 3 quarters · filed 2026-05-07 | -$38.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$16.18M derived: sum of 2 quarters · filed 2026-03-05 | -$29.92M derived: sum of 3 quarters · filed 2026-08-06 | -$38.21M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$9.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$23.36M derived: sum of 2 quarters · filed 2026-08-06 | -$31.64M 10-Q · filed 2025-11-13 | -$37.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$13.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$22.03M 10-Q · filed 2026-08-06 | -$27.91M derived: sum of 3 quarters · filed 2026-08-06 | -$34.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$8.28M 10-Q · filed 2026-05-07 | -$14.16M derived: sum of 2 quarters · filed 2026-05-07 | -$20.99M derived: sum of 3 quarters · filed 2026-05-07 | -$27.21M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$12.71M derived: sum of 2 quarters · filed 2026-03-05 | -$18.92M derived: sum of 3 quarters · filed 2026-03-05 | -$23.45M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$6.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$13.04M derived: sum of 2 quarters · filed 2025-11-13 | -$17.57M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$6.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$10.75M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$4.53M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$22.61M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |